{"title":"2024台湾糖尿病肾病临床实践指南-执行摘要。","authors":"Sheng-Chiang Su, Tieng-Chun Chang, Yi-Wen Chiu, Chih-Hsun Chu, Yueh-Han Hsu, Chin-Sung Kuo, Chun-Chuan Lee, Ming-Hsun Lin, Chun-Liang Lin, Yuh-Feng Lin, Da-Wei Lin, Hui-Yu Peng, Shwu-Pyng Su, Yi-Chun Tsai, Yao-Hsien Tseng, Jun-Sing Wang, Tsai-Jung Wang, Yi-Sun Yang, Chien-Ning Huang, Horng-Yih Ou, Mai-Szu Wu","doi":"10.1016/j.jfma.2025.08.020","DOIUrl":null,"url":null,"abstract":"<p><p>Scientific advances and development in the management of diabetes including use of new glucose-lowering agents for cardiorenal protection in diabetic patients prompted revision of local clinical practice guideline for diabetic kidney disease (DKD). Multiple cross-disciplinary professional meetings were held in 2023 and 2024 by experts from the Diabetes Association of the Republic of China (Taiwan), the Taiwanese Association of Diabetes Educators and the Taiwan Society of Nephrology to review the latest evidence and to develop updated recommendations, taking local epidemiology, circumstances and relevant local guidelines into considerations. From screening and diagnosis; risk classification and monitoring; lifestyle modifications; glycemic, blood pressure and lipid management; to the use of cardiorenal protective medications and complication management, the 2024 Taiwan Clinical Practice Guideline for DKD aims to offer up-to-date reference and comprehensive guidance to local practitioners for optimization of DKD patient care.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"2024 Taiwan clinical practice guideline for diabetic kidney disease - an executive summary.\",\"authors\":\"Sheng-Chiang Su, Tieng-Chun Chang, Yi-Wen Chiu, Chih-Hsun Chu, Yueh-Han Hsu, Chin-Sung Kuo, Chun-Chuan Lee, Ming-Hsun Lin, Chun-Liang Lin, Yuh-Feng Lin, Da-Wei Lin, Hui-Yu Peng, Shwu-Pyng Su, Yi-Chun Tsai, Yao-Hsien Tseng, Jun-Sing Wang, Tsai-Jung Wang, Yi-Sun Yang, Chien-Ning Huang, Horng-Yih Ou, Mai-Szu Wu\",\"doi\":\"10.1016/j.jfma.2025.08.020\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Scientific advances and development in the management of diabetes including use of new glucose-lowering agents for cardiorenal protection in diabetic patients prompted revision of local clinical practice guideline for diabetic kidney disease (DKD). Multiple cross-disciplinary professional meetings were held in 2023 and 2024 by experts from the Diabetes Association of the Republic of China (Taiwan), the Taiwanese Association of Diabetes Educators and the Taiwan Society of Nephrology to review the latest evidence and to develop updated recommendations, taking local epidemiology, circumstances and relevant local guidelines into considerations. From screening and diagnosis; risk classification and monitoring; lifestyle modifications; glycemic, blood pressure and lipid management; to the use of cardiorenal protective medications and complication management, the 2024 Taiwan Clinical Practice Guideline for DKD aims to offer up-to-date reference and comprehensive guidance to local practitioners for optimization of DKD patient care.</p>\",\"PeriodicalId\":17305,\"journal\":{\"name\":\"Journal of the Formosan Medical Association\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-08-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Formosan Medical Association\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jfma.2025.08.020\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Formosan Medical Association","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jfma.2025.08.020","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
2024 Taiwan clinical practice guideline for diabetic kidney disease - an executive summary.
Scientific advances and development in the management of diabetes including use of new glucose-lowering agents for cardiorenal protection in diabetic patients prompted revision of local clinical practice guideline for diabetic kidney disease (DKD). Multiple cross-disciplinary professional meetings were held in 2023 and 2024 by experts from the Diabetes Association of the Republic of China (Taiwan), the Taiwanese Association of Diabetes Educators and the Taiwan Society of Nephrology to review the latest evidence and to develop updated recommendations, taking local epidemiology, circumstances and relevant local guidelines into considerations. From screening and diagnosis; risk classification and monitoring; lifestyle modifications; glycemic, blood pressure and lipid management; to the use of cardiorenal protective medications and complication management, the 2024 Taiwan Clinical Practice Guideline for DKD aims to offer up-to-date reference and comprehensive guidance to local practitioners for optimization of DKD patient care.
期刊介绍：
Journal of the Formosan Medical Association (JFMA), published continuously since 1902, is an open access international general medical journal of the Formosan Medical Association based in Taipei, Taiwan. It is indexed in Current Contents/ Clinical Medicine, Medline, ciSearch, CAB Abstracts, Embase, SIIC Data Bases, Research Alert, BIOSIS, Biological Abstracts, Scopus and ScienceDirect.
As a general medical journal, research related to clinical practice and research in all fields of medicine and related disciplines are considered for publication. Article types considered include perspectives, reviews, original papers, case reports, brief communications, correspondence and letters to the editor.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
